
Erectile Dysfunction Treatment Drugs Market Insights, Global Outlook and Forecast 2022-2028
Discover the latest insights into the booming Erectile Dysfunction Treatment Drugs Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.
The latest research study released by Market IntelliX evaluates market size and forecasts of Erectile Dysfunction Treatment Drugs in Global, including the following market information:
Global Erectile Dysfunction Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erectile Dysfunction Treatment Drugs market was valued at 4995.6 million in 2021 and is projected to reach US$ 7328.5 million by 2028, at a CAGR of 5.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phosphodiesterase Type 5 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erectile Dysfunction Treatment Drugs include Pfizer Inc., Dong-A Pharmaceutical Co. Ltd, Vivus, Inc., Meda Pharmaceuticals, Bayer AG, Johnson & Johnson Services, Apricus Biosciences and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Erectile Dysfunction Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Erectile Dysfunction Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1
Global Erectile Dysfunction Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Erectile Dysfunction Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Erectile Dysfunction Treatment Drugs revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Erectile Dysfunction Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Erectile Dysfunction Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Erectile Dysfunction Treatment Drugs Overall Market Size
2.1 Global Erectile Dysfunction Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Erectile Dysfunction Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Erectile Dysfunction Treatment Drugs Players in Global Market
3.2 Top Global Erectile Dysfunction Treatment Drugs Companies Ranked by Revenue
3.3 Global Erectile Dysfunction Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Erectile Dysfunction Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Erectile Dysfunction Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Erectile Dysfunction Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Erectile Dysfunction Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Phosphodiesterase Type 5 Inhibitors
4.1.3 Prostaglandin E1
4.2 By Type - Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Erectile Dysfunction Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Erectile Dysfunction Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Erectile Dysfunction Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Erectile Dysfunction Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Erectile Dysfunction Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Erectile Dysfunction Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Erectile Dysfunction Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Erectile Dysfunction Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Erectile Dysfunction Treatment Drugs Revenue, 2017-2028
6.3.2 US Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Erectile Dysfunction Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.4.3 France Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Erectile Dysfunction Treatment Drugs Revenue, 2017-2028
6.5.2 China Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.5.6 India Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Erectile Dysfunction Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Erectile Dysfunction Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporate Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Major Product Offerings
7.1.4 Pfizer Inc. Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Inc. Key News
7.2 Dong-A Pharmaceutical Co. Ltd
7.2.1 Dong-A Pharmaceutical Co. Ltd Corporate Summary
7.2.2 Dong-A Pharmaceutical Co. Ltd Business Overview
7.2.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Major Product Offerings
7.2.4 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Dong-A Pharmaceutical Co. Ltd Key News
7.3 Vivus, Inc.
7.3.1 Vivus, Inc. Corporate Summary
7.3.2 Vivus, Inc. Business Overview
7.3.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Major Product Offerings
7.3.4 Vivus, Inc. Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Vivus, Inc. Key News
7.4 Meda Pharmaceuticals
7.4.1 Meda Pharmaceuticals Corporate Summary
7.4.2 Meda Pharmaceuticals Business Overview
7.4.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Major Product Offerings
7.4.4 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Meda Pharmaceuticals Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Erectile Dysfunction Treatment Drugs Major Product Offerings
7.5.4 Bayer AG Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 Bayer AG Key News
7.6 Johnson & Johnson Services
7.6.1 Johnson & Johnson Services Corporate Summary
7.6.2 Johnson & Johnson Services Business Overview
7.6.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Major Product Offerings
7.6.4 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 Johnson & Johnson Services Key News
7.7 Apricus Biosciences
7.7.1 Apricus Biosciences Corporate Summary
7.7.2 Apricus Biosciences Business Overview
7.7.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Major Product Offerings
7.7.4 Apricus Biosciences Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Apricus Biosciences Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Erectile Dysfunction Treatment Drugs Major Product Offerings
7.8.4 Eli Lilly Erectile Dysfunction Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 Eli Lilly Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Erectile Dysfunction Treatment Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|